Presbyopia,Healthy Subject,Subjects with Presbyopia
Showing 1 - 25 of >10,000
Eye Diseases, Presbyopia, Refractive Errors Trial in Newport Beach (Aceclidine + Brimonidine, Aceclidine)
Recruiting
- Eye Diseases
- +5 more
- Aceclidine + Brimonidine
- Aceclidine
-
Newport Beach, CaliforniaSite #101
Jul 7, 2023
Presbyopia Trial (Phentolamine Opthalmic Solution 0.75%, Placebo, Low dose pilocarpine)
Not yet recruiting
- Presbyopia
- Phentolamine Opthalmic Solution 0.75%
- +3 more
- (no location specified)
Dec 2, 2022
Presbyopia Trial in Glendale, Memphis (0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo)
Recruiting
- Presbyopia
- 0.1% STN1013600 ophthalmic solution
- +2 more
-
Glendale, California
- +1 more
Jan 12, 2023
Presbyopia, Near Vision, Miosis Trial in Chandler, Glendale (Aceclidine+Brimonidine combination ophthalmic solution, Placebo,
Recruiting
- Presbyopia
- +3 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Chandler, Arizona
- +1 more
Mar 2, 2023
Presbyopia Trial in Memphis (BRIMOCHOL™ PF, Carbachol PF, Brimonidine tartrate)
Recruiting
- Presbyopia
- BRIMOCHOL™ PF
- +2 more
-
Memphis, TennesseeTotal Eye Care, PA
Apr 25, 2022
Refractive Error Trial in United States (iDesign Refractive Studio with STAR S4 IR® Excimer laser System)
Recruiting
- Refractive Error
- iDesign Refractive Studio with STAR S4 IR® Excimer laser System
-
Los Angeles, California
- +9 more
Jan 23, 2023
Presbyopia Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Pilocarpine, Placebo)
Completed
- Presbyopia
- Phentolamine Ophthalmic Solution 0.75%
- +2 more
-
Laguna Hills, California
- +16 more
Jun 20, 2022
Presbyopia Trial in Crystal River (BRIMOCHOL™ PF, Carbachol PF, Vehicle)
Recruiting
- Presbyopia
- BRIMOCHOL™ PF
- +2 more
-
Chandler, Arizona
- +42 more
Sep 30, 2022
Healthy Trial in Hangzhou (LPM3480392, Placebo)
Completed
- Healthy
- LPM3480392
- Placebo
-
Hangzhou, Zhejiang, ChinaThe second affiliated hosipital zhejiang university school of me
May 15, 2023
Healthy Subject Trial in Chengdu (GS3-007 oral liquid)
Not yet recruiting
- Healthy Subject
- GS3-007 oral liquid
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023
Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)
Completed
- Healthy Subject
- Neomazine Tab. 100mg
- Myungin Chlorpromazine HCl Tab. 100mg
-
Seoul, Korea, Republic ofWhan In Pharm.
Nov 23, 2023
Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)
Completed
- Healthy
- Test Empagliflozin And Linagliptin Tablets
- Reference Empagliflozin And Linagliptin tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023
Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)
Completed
- Healthy Subject
- CT-P41
- US-licensed Prolia
-
Seongnam, Bundang-gu, Korea, Republic of
- +1 more
Sep 7, 2023
Healthy Subject Trial in Xingtai (STSA-1002 Injection, STSA-1005 Injection)
Recruiting
- Healthy Subject
- STSA-1002 Injection
- STSA-1005 Injection
-
Xingtai, Hebei, ChinaThe Second Affiliated Hospital Of Xingtai Medical College
Nov 22, 2022
Healthy Subject Trial in Beijing (Orelabrutinib and (orelabrutinib tablet simulator), Orelabrutinib, Placebo (orelabrutinib
Active, not recruiting
- Healthy Subject
- Orelabrutinib and placebo (orelabrutinib tablet simulator)
- +3 more
-
Beijing, ChinaBeijing GoBroad Boren Hospital
Dec 19, 2022
Presbyopia Trial in Mexico City (Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac, Pilocarpine
Recruiting
- Presbyopia
- Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac
- +2 more
-
Mexico City, MexicoOptall Vision
Aug 14, 2021